Inhibitory effect of biochanin A on HIV-1 and early activation of human CD4+ lymphocytes

Chinese Pharmacological Bulletin

Volumn 23, Issue 2, 2007, Pages 214-218

  Lin, Chang Le ^a   Zeng, Yao Ying ^a   Zeng, Xiang Feng ^a   Zhao, Ling Zhai ^a   Wang, Tong ^a   Li, Hai Xian ^a   Li, Li Ping ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Biochanin A; Cell fusion; Early activation; HIV 1; p24 antigen

Indexed keywords

ANTIGEN P24; BIOCHANIN A; CD69 ANTIGEN;

ARTICLE; CD4+ T LYMPHOCYTE; CELL FUSION; DRUG EFFECT; DRUG INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE ACTIVATION; PROTEIN EXPRESSION;

EID: 34247482788     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Ono K, Nakane H, Fukushima M, et al. Inhibition by reverse transcriptase activi-ty of a flavonoid compound, 5,6,7-trihydroxyflavone[J]. Biochem Biophys Res Commun, 1989,160(3):982.
2. Hendrich A B, Zugaj J, Michalak K. Biochanin A similarly influences the fluidity of liposomes formed from charged and zwitterionic lipids[J]. Cell Mol Biol Lett, 2002,7(2):284.
3. Ying C, Hsu J T, Shieh S C. Growth inhibition of human endothelial cells by the phytoestrogen biochanin A, a metabolite of genistein[J]. Br J Nutr, 2001,85(5):615-20.
4. Fung M C, Szeto Y Y, Leung K N, et al. Effects of biochanin A on the growth and differentiation of myeloid leukemia WEHI-3B (JCS) cells[J]. Life Sci, 1997,61(2):105-15.
5. Rice L, Samedi V G, Medrano T A, et al. Mechanisms of the growth inhibitory effects of the isoflavonoid biochanin A on LNCaP cells and xenografts[J]. Prostate, 2002,52(3):201-12.
6. Rudi P, Jan B, Masanori B, et al. Rapid and automated tetrazoliumbased colorimetric assay for the detection of anti-HIV compounds[J]. Virol Meth, 1988,20:309.
7. Lu L, Liu S W, Jiang S B, et al. Tannin inhibits HIV-1 entry by targeting gp41[J]. Acta Pharmacol Sin, 2004,25(2):213-8.
8. Rice W G, Bader J P. Discovery and in vitro development of AIDS antiviral drugs as biopharmaceuticals[J]. Adv Pharmacol, 1995, 6:389-438.
9. Fung H B, Guo Y. A fusion inhibitor for the treatment of HIV infection[J]. Criti Therap, 2004,26(3):352-78.
10. Liu S W, Wu S G, Jiang S B, et al. Addvancement in developing a new class of anti-AIDS drugs: HIV entry inhibitors[J]. Chin Pharmacol Bull, 2005,21(9):1034-40.
11. Zeng Y Y. New concepts in pathogenesis of HIV infection[J]. J Henan College Trad Chin Med, 2005,20(119):1-5.
12. Rizzardi G P, Harari A, Capiluppi B, et al. Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy[J]. J Clin Invest, 2002,109(5):681-8.